AI Summary
Thinking
Thinking
We reviewed 3 live results for cyp2d6 gene test and narrowed them down to the 3 options that look most worth comparing first.
The options are BRCA Gene Test, SurePrint G3 Gene Expression Microarrays and 70-Gene Cancer Genetic Test.
Source: MedDx, 麥迪體檢
Description
MedDx provides BRCA Gene Testing in Hong Kong to assess hereditary risks for breast and ovarian cancer. The test requires a 5 mL blood sample and provides reports in 2 to 4 weeks at Mong Kok or Wan Chai centres. Options include a common 2-gene panel (BRCA1/2) for $4800 or a 53-gene comprehensive panel for $7800. It is suitable for individuals with a family history of breast or ovarian cancer or early-onset diagnosis, with optional specialist doctor consultations.
Best for
Individuals with a family history of breast or ovarian cancer, People with early-onset breast cancer, Evaluating hereditary cancer risk and Treatment decision planning
Rate this product
Source: SelectScience
Description
SurePrint G3 Gene Expression Microarrays from Agilent Technologies offer comprehensive coverage of human genes and transcripts, including large intergenic non-coding RNAs. Featuring a dynamic range over five orders of magnitude for sensitive detection of low and high expressors, content is sourced from RefSeq, Ensembl, UniGene Human Genome, and GenBank databases. Slides are available in formats containing eight 60K or four 44K microarrays as single slides or kits, with customizable content options for flexible experimental design.
Best for
researchers, molecular biologists, gene expression profiling and transcriptome analysis
Rate this product
Source: MedDx 香港麥迪基因
Description
The 70-Gene Cancer Genetic Test by MedDx is a comprehensive hereditary cancer screening panel available at Mong Kok and Wan Chai centres in Hong Kong. Requiring a 5 mL blood sample processed by a US laboratory with results delivered in 2 to 4 weeks, the test analyzes 70 genes associated with hereditary cancers across key organ systems including breast, gynecologic, gastrointestinal, endocrine, genitourinary, skin, and nervous systems.
Best for
People with a family history of cancer or hereditary risk, Individuals with abnormal findings during health check-ups, Screening hereditary cancer genetic risks and Adding preventative health protection for families
Rate this product
| Compare | #1BRCA Gene Test | #2SurePrint G3 Gene Expression Microarrays | #370-Gene Cancer Genetic Test |
|---|---|---|---|
| Source | MedDx, 麥迪體檢 | SelectScience | MedDx 香港麥迪基因 |
| Description | MedDx provides BRCA Gene Testing in Hong Kong to assess hereditary risks for breast and ovarian cancer. The test requires a 5 mL blood sample and provides reports in 2 to 4 weeks at Mong Kok or Wan Chai centres. Options include a common 2-gene panel (BRCA1/2) for $4800 or a 53-gene comprehensive panel for $7800. It is suitable for individuals with a family history of breast or ovarian cancer or early-onset diagnosis, with optional specialist doctor consultations. | SurePrint G3 Gene Expression Microarrays from Agilent Technologies offer comprehensive coverage of human genes and transcripts, including large intergenic non-coding RNAs. Featuring a dynamic range over five orders of magnitude for sensitive detection of low and high expressors, content is sourced from RefSeq, Ensembl, UniGene Human Genome, and GenBank databases. Slides are available in formats containing eight 60K or four 44K microarrays as single slides or kits, with customizable content options for flexible experimental design. | The 70-Gene Cancer Genetic Test by MedDx is a comprehensive hereditary cancer screening panel available at Mong Kok and Wan Chai centres in Hong Kong. Requiring a 5 mL blood sample processed by a US laboratory with results delivered in 2 to 4 weeks, the test analyzes 70 genes associated with hereditary cancers across key organ systems including breast, gynecologic, gastrointestinal, endocrine, genitourinary, skin, and nervous systems. |
| Best for | Individuals with a family history of breast or ovarian cancer, People with early-onset breast cancer, Evaluating hereditary cancer risk and Treatment decision planning | researchers, molecular biologists, gene expression profiling and transcriptome analysis | People with a family history of cancer or hereditary risk, Individuals with abnormal findings during health check-ups, Screening hereditary cancer genetic risks and Adding preventative health protection for families |
| Action | MedDx, 麥迪體檢 | SelectScience | MedDx 香港麥迪基因 |
| Rate this product |
"BRCA Gene Test from MedDx, 麥迪體檢."
Note: TopFind AI compiles product and service information for general comparison purposes only.